Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
•
Primary Care
How long do you typically wait before starting anticoagulation after holding Leqembi/Kisunla in patients with cognitive impairment?
What is the typical washout period For these medications?
Related Questions
Is a history of coronary artery disease and afib a contraindication to using donepezil?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
How do you approach management of neurocognitive and memory deficits in post concussive syndrome?
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
How significant are the cardiovascular side effects, such as hypertension, associated with valproate?
Do you recommend any particular type of contraceptive use in young patients with strokes of unclear etiology?
Is there utility to ordering biochemical screening labs for global developmental delay?
When, if ever, would you pursue genetic testing in an asymptomatic child with multiple first-degree relatives with epilepsy?
How do you counsel patients with mild congenital myopathy about exercise limitations?
When do you consider using stimulants in patients with cognitive impairments secondary to traumatic brain injury?